Estrogen receptor-α and C-ERBB-4 expression in breast carcinomas

Virchows Archiv

Volumn 439, Issue 1, 2001, Pages 62-69

  Suo, Zhenhe ^a   Siri Berner, Heidi ^a   Risberg, Björn ^a   Karlsson, Mats G ^b   Nesland, Jahn M ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b ÖREBRO MEDICAL CENTRE HOSPITAL   (Sweden)

Author keywords

c erbB 4; ER; Immunohistochemistry; RT PCR

Indexed keywords

ESTROGEN RECEPTOR ALPHA; MESSENGER RNA;

ADULT; AGED; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CELL CULTURE; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MICROSCOPY; ONCOGENE C ERB; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

BREAST NEOPLASMS; DISSECTION; DNA PRIMERS; ESTROGEN RECEPTOR ALPHA; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; MICROMANIPULATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TUMOR CELLS, CULTURED;

EID: 0034918674     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280000392     Document Type: Article

References (57)

1. Immunohistochemical estrogen receptor determination in paraffin-embedded tissue. Prediction of response to hormonal treatment in advanced breast cancer
2. Medullary carcinoma is associated with expression of intercellular adhesion molecule-1. Implication to its morphology and its clinical behavior
3. Type 1 receptor tyrosine kinases are differentially phosphory-lated in mammary carcinoma and differentially associated with steroid receptors
4. Estrogen-receptor status and response to chemotherapy in early and advanced breast cancer
5. Biologic markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer
6. Selection of hormone-responsive advanced breast cancer with a cytoplasmic estrogen receptor assay. Analysis of 100 cases
7. Survival of premenopausal breast carcinoma patients in relation to menstrual cycle timing of surgery and estrogen receptor/progesterone receptor status of the primary tumor
8. Estrogen receptor status as a prognostic indicator for stage I breast cancer patients
9. Estrogen receptor synthesis and turnover in MCF-7 breast cancer cells measured by a density shift technique
10. Estrogen and progesterone receptor proteins in breast cancer
11. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up
12. Laser capture microdissection
13. Loss of an estrogen receptor isoform (ER alpha delta 3) in breast cancer and the consequences of its reexpression: Interference with estrogen-stimulated properties of malignant transformation
14. Prognostic relevance of carcinoembryonic antigen and estrogen receptor status in breast cancer patients
15. Regulation of estrogen receptor alpha function in breast cancer
16. Oestrogen receptor analysis of paraffin sections and cytosol samples of primary breast cancer in relation to outcome after adjuvant tamoxifen treatment
17. Oestradiol stimulates growth of oestrogen receptor-negative MDA-MB-231 breast cancer cells in immunodeficient mice by reducing cell loss
18. Oestrogen and progesterone receptors in primary breast cancer: A population study
19. Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor
20. Estrogen receptor quantitation and staging as complementary prognostic indicators in breast cancer: A study of 583 patients
21. Human oestrogen receptor cDNA: Sequence, expression and homology to v-erb-A
22. Microdissection of stained archival tissue
23. Estrogen receptor status and dietary intakes in breast cancer patients
24. The primary use of endocrine therapies
25. Sequence variants of the estrogen receptor (ER) gene found in breast cancer patients with ER negative and progesterone receptor positive tumors
26. ErbB4 signaling in the mammary gland is required for lobuloalveolar development and Stat5 activation during lactation
27. Expression of mRNA for heregulin and its receptor, ErbB-3 and ErbB-4, in human upper gastrointestinal mucosa
28. c-erbB-4 protein expression in human breast cancer
29. Estrogen receptor expression in benign breast epithelium and breast cancer risk
30. c-erbB3 and c-erbB4 expression is a feature of the endocrine responsive phenotype in clinical breast cancer
31. NDF induces expression of a novel 46 kD protein in estrogen receptor positive breast cancer cells
32. Low oestrogen receptor alpha expression in normal breast tissue underlies low breast cancer incidence in Japan
33. Expression of estrogen receptor beta1, beta2, and beta5 messenger RNAs in human breast tissue
34. Evaluation of estrogen receptor assays in human breast cancer tissue
35. ER beta: Identification and characterization of a novel human estrogen receptor
36. Variant estrogen receptor mRNA species detected in human breast cancer biopsy samples
37. Novel mutations in the estrogen receptor messenger RNA in human breast cancers
38. Steroid hormone receptors in breast cancer management
39. Oestrogen and progesterone receptor assays in breast tumours. The Prince Henry's hospital experience 1983-1990
40. Frequency and distribution of estrogen receptor-positive cells in normal, nonlactating human breast tissue
41. Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family
42. Differential expression of estrogen receptor-alpha and -beta messenger RNAs as a potential marker of ovarian carcinogenesis
43. Effects of an exon 5 variant of the estrogen receptor in MCF-7 breast cancer cells
44. Prognostic value of estrogen receptor determinations in patients with breast cancer
45. In situ hybridization of chromosome 6 on fine-needle aspirates from breast carcinomas: Comparison of numerical abnormalities and ER/PgR status and staining pattern
46. Semi-quantitative RT-PCR for comparison of mRNAs in cells with different amounts of housekeeping gene transcripts
47. Direct action of estrogen on sequence of progression of human preneoplastic breast disease
48. Oestrogen receptor expression in the normal and pre-cancerous breast
49. Expression of the c-erbB-4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumour types
50. Nuclear expression of the c-erbB-4/HER-4 growth factor receptor in invasive breast cancers
51. Identification of sequence alterations in the upstream regulatory region of the estrogen receptor gene in an ER-negative breast cancer cell line
52. Type 1 protein tyrosine kinases in benign and malignant breast lesions
53. ErbB-4 ribozymes abolish neuregulin-induced mitogenesis
54. Ribozyme-mediated down-regulation of ErbB-4 in estrogen receptor-positive breast cancer cells inhibits proliferation both in vitro and in vivo
55. Isolation and radiation hybrid mapping of dinucleotide repeat polymorphism at the human estrogen receptor beta locus
56. Reliability of estrogen receptors in predicting response to antiestrogens
57. Expression of estrogen receptor beta messenger RNA variant in breast cancer